🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

While there was a benefit in those without ESR1mutation, the benefit was much greater in those with the mutation, hence approval in only those with mutant ESR1. Another reason is that in those w/o ESR1 there was higher withdrawal of consent, raising concerns about data. #SABCS23

Love seeing dear friends and amazing patient advocates on the stage SABCS!! Janice Cowden has incredible wisdom to share. #SABCS23 AACR

And we're off. First day of #SABCS23 it's just brilliant to be here with Lori Petitti Lori Petitti immersed in the discussions around discovery and learning for #Breastcancer Research. Our #ILC #LobularBreastCancer Session begins at 3.25 central time today.

Look who is front page of the SABCS newspaper on day #1? 😍 Julia Maués GRASP #bcsm #SABCS23

We need more non inferiority assessments so that drugs that are pretty darn close in efficacy but have different side effects are approved so WE can choose what WE find acceptable!!! #SABCS23

What to do after progression on a CDK4/6 inhibitor? First, remember all people are not the same!!! We should try to assess things like endocrine sensitivity (presented by Dr Carlos Barrios) #SABCS23

Lobular educational session starting with Christine Desmedt. Thanks to Lobular Breast Cancer Alliance for sponsoring this session. Dr. Steffi Oesterreich UPMC Hillman Cancer Center

You see it here, in bold red: we are not all the same!! Individualize therapy and engage in shared decision making!! #SABCS23

Extraordinary #patientadvocate presenter, Abigail, Abigail Johnston shares her “disclosures” (her boys), & the approximate # of treatment decisions (193) she’s had to make since her de novo #metastaticbreastcancer dx in 2017. #bcsm

An absolute highlight of #SABCS23!!!

“How often do you ask your patients what’s important to them?” says Dr. Kelly Shanahan, challenging the panelists. Patients treatment goals and wishes differ amongst patients, but also change over time. #bcsm #metastaticbreastcancer #SABCS23

Excellent discussion of ctDNA abstracts by Ben Ho Park SABCS -MONARCHE -DARE -TRACER -PlasmaMATCH *clinical validation demonstrated - association b/t MRD+ and recurrence *clinical utility for MRD surveillance NOT yet demonstrated but studies underway

#HER2CLIMB02 presented by Dr. Hurvitz looking at TDM1 +\- tucatinib in 2L+ (no prior TDXd allowed) ~44% had brain mets 🔺PFS improved 7.4 to 9.5 months all-comers 🔺Among those with active brain mets , PFS improved 5.7 to 7.8 months #SABCS23 SABCS #bcsm

👇👇👇& big🫶 Drs. Nancy Lin, MD and Sara Tolaney from all #breastcancerbrainsmets patients #bcsm #mbc

Fascinating sesh with inspiring MDs #bcsm

Brilliant discussion by Dr. Sarah Sammons Dr Sarah Sammons on management of pts with HER2+brain mets. Worth a watch if you missed it!

⁦Alamo Breast Cancer⁩ first Hot Topics of #SABCS23 with Ginger Borges, MD, JennyChang, MD, ⁦@naborala⁩ - Dr. Borges highlights of today include recognition for #postpartumbreastcancer (#PPBC) as a unique subset distinct from Pregnancy-associated (#PrBC) breast cancer #bcsm

Thank you for the excellent & patient-centered case discussions ;) ⁦PeerView⁩ #SABCS23 Drs. ⁦Erika Hamilton, MD, FASCO⁩ ⁦Hope Rugo⁩ ⁦Komal Jhaveri⁩ ⁦Paolo Tarantino⁩

Incorporating #therightdose (Patient Centered Dosing Initiative/PCDI) into case discussions at ⁦PeerView⁩ with a tribute to PCDI Founder Ann Loeser🫶⁦Erika Hamilton, MD, FASCO⁩ ⁦Hope Rugo⁩ ⁦Komal Jhaveri⁩ ⁦Paolo Tarantino⁩ #bcsm #SABCS23

Clinicians, Researchers & Patient Advocates Partnering at #SABCS23 on #PostpartumBreastCancer #PPBC - so grateful for the work of Drs. Virginia Borges & Pepper Schedin to solve ? in this verified high risk subset for #mbc #bcsm